Gianluca Pirozzi Selected Research

Interleukin-4 Receptors (Interleukin 4 Receptor)

1/2020	IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis.
1/2019	Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis.
1/2019	Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
1/2019	Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis.
12/2016	Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
6/2013	Dupilumab in persistent asthma with elevated eosinophil levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianluca Pirozzi Research Topics

Disease

27	Atopic Dermatitis (Atopic Eczema) 10/2021 - 07/2014
25	Asthma (Bronchial Asthma) 01/2021 - 01/2013
15	Inflammation (Inflammations) 01/2021 - 06/2013
9	Injection Site Reaction 01/2020 - 06/2013
9	Eczema 01/2020 - 07/2014
7	Rhinosinusitis 01/2021 - 01/2019
7	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2016
5	Conjunctivitis 01/2020 - 12/2016
4	Infections 01/2020 - 07/2014
4	Pruritus (Itching) 05/2019 - 07/2014
4	Nasopharyngitis 02/2016 - 06/2013
3	Headache (Headaches) 02/2016 - 06/2013
2	Pain (Aches) 10/2021 - 05/2019
2	Eosinophilic Esophagitis 01/2021 - 01/2020
2	Allergic Rhinitis 11/2020 - 01/2018
2	Perennial Allergic Rhinitis 11/2020 - 01/2018
2	Body Weight (Weight, Body) 01/2020 - 01/2020
2	Polyps 11/2019 - 01/2019
2	Hyperplasia 01/2019 - 12/2014
2	Eosinophilia 01/2018 - 01/2018
2	Sinusitis 02/2016 - 01/2016
1	Deglutition Disorders (Dysphagia) 01/2020
1	Airway Obstruction (Choking) 01/2020
1	Herpes Zoster 06/2019
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 06/2019
1	Whooping Cough (Pertussis) 01/2019
1	Tetanus 01/2019
1	Immune System Diseases (Immune Disorders) 01/2018
1	Sneezing 01/2018
1	Nasal Obstruction 01/2018
1	Rhinorrhea 01/2018
1	Hypersensitivity (Allergy) 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2016
1	Nausea 06/2013
1	Virus Diseases (Viral Diseases) 12/2004

Drug/Important Bio-Agent (IBA)

44	dupilumabIBA 10/2021 - 01/2013
19	Interleukin-13IBA 01/2021 - 07/2014
14	Interleukin-4 (Interleukin 4)IBA 01/2021 - 07/2014
13	Monoclonal AntibodiesIBA 01/2021 - 06/2013
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2013
8	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 02/2016
7	InterleukinsIBA 11/2020 - 01/2016
6	Immunoglobulin E (IgE)IBA 11/2020 - 01/2016
6	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2020 - 06/2013
5	CytokinesIBA 01/2019 - 12/2004
4	Pharmaceutical PreparationsIBA 11/2019 - 06/2013
3	AllergensIBA 11/2020 - 01/2017
3	GlucocorticoidsIBA 01/2018 - 06/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2020 - 01/2020
2	Bronchodilator Agents (Bronchodilators)IBA 01/2020 - 01/2018
2	Immunoglobulin A (IgA)IBA 01/2020 - 10/2017
2	ChemokinesIBA 01/2019 - 12/2014
1	AlbuminsIBA 01/2020
1	AntibodiesIBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2019
1	Janus Kinase InhibitorsIBA 06/2019
1	Immunologic Factors (Immunomodulators)IBA 06/2019
1	Tumor Necrosis FactorsIBA 06/2019
1	Filaggrin ProteinsIBA 01/2019
1	VaccinesIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Chemokine CCL18IBA 01/2019
1	Chemokine CCL24IBA 01/2019
1	Keratin-16 (Keratin 16)IBA 01/2019
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 01/2019
1	Chemokine CCL26IBA 01/2019
1	loricrinIBA 01/2019
1	ClaudinsIBA 01/2019
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2019
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2019
1	Biological ProductsIBA 05/2018
1	PlacebosIBA 01/2018
1	AntigensIBA 01/2017
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 02/2016
1	Nasal SpraysIBA 02/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	Messenger RNA (mRNA)IBA 12/2014
1	Calcineurin InhibitorsIBA 07/2014
1	Poly I-CIBA 12/2004
1	RNA (Ribonucleic Acid)IBA 12/2004

Therapy/Procedure

6	Therapeutics 09/2016 - 06/2013
1	Biological Therapy 05/2018
1	Aftercare (After-Treatment) 01/2016